DE-LYCRA
14.9.2021 16:12:07 CEST | Business Wire | Press release
The LYCRA Company , a global leader in innovative solutions for stretch and performance technologies for the apparel industry, introduces today a breakthrough technology, LYCRA® ADAPTIV fiber. This fiber allows garments to have a better fit for various lifestyles, movements and different body types. The accompanying new brand identity– LYCRA® ADAPTIV – was created to communicate these new and beneficial motion attributes.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210914005789/en/
Made from a revolutionary polymer, this patent-pending, adaptive fiber has a unique chemistry that allows it to adjust to a wearer’s functional needs in a hybrid manner. This means that when the wearer is at rest, the polymer adapts its compressive holding force to deliver the right fit, shape and control. And when the wearer is in motion, the polymer adapts its elasticity to deliver improved comfort in motion and a second-skin effect allowing the garment to stay in place better. Garments made with fabrics containing LYCRA® ADAPTIV fiber are durable and are also easier to put on and take off.
“Consumers are seeking garments that offer greater versatility -- from work to leisure to social, and also from season to season and year to year,” says Steve Stewart, chief brand and innovation officer at The LYCRA Company. “They want garments that can adapt to their individual needs and lifestyle as well as ones that can adapt to their unique body type, even when their body size or shape may change or fluctuate. LYCRA® ADAPTIV fiber is the answer to satisfy all of these consumer needs.”
The LYCRA Company has conducted internal studies to assess wear performance by comparing fabrics and garments containing LYCRA® ADAPTIV fiber versus the same fabrics and garments containing only generic spandex. Results show several advantages in using LYCRA® ADAPTIV fiber including comfort-in-motion and second skin performance accompanied by shape retention and greater freedom of movement with a comfortable hold. Size inclusivity is also a key benefit in that LYCRA® ADAPTIV fiber promotes one-size-fits-more. The softer stretch within the wearing zone allows for a widened fit window that covers a broader range of body shapes within a given size. This makes the one-size-fits-more approach, and the potential reduction of SKUs, a practical possibility.
“Size inclusivity is not a buzzword – it is increasingly important to today’s consumers,” says Deana Stankowski, strategic marketing director for active, intimates, and swim at The LYCRA Company. “Every consumer’s body is unique and they want clothes they feel were designed for them – clothes that increase their personal comfort as well as their confidence level. Size alone is an inadequate indication of body type and body shape. Therefore, traditionally-sized garments may not fit every consumer within that size. That’s what makes LYCRA® ADAPTIV fiber so revolutionary --- it allows garments made with this fiber to adapt to many body shapes within a size range.”
The LYCRA Company worked with DIP agency to develop a new LYCRA® sub-brand identity that communicates the “adaptive” nature of this new fiber. The global agency FCB was selected to develop the campaign “LYCRA® ADAPTIV fiber Adapts to your world.” The campaign leverages computer-generated graphics to promote the adaptive nature of this groundbreaking spandex (elastane) fiber innovation.
In addition, two upcoming trade events will support the launch of LYCRA® ADAPTIV fiber. LYCRA® ADAPTIV fiber will be launched in the Asia-Pacific region at The LYCRA Company’s pavilion at Intertextile Shanghai -- booth 1.1 – E51 located in Hall 1.1 -- taking place October 9-11 at the National Exhibition and Convention Center in Shanghai. For a virtual booth tour and daily show highlights, visit https://www.lycra.com/en/2021Intertextile . And, LYCRA® ADAPTIV fiber will also be launched in North America to the denim industry via exclusive, invite-only virtual meetings being held on September 21-22.
Additional information on LYCRA® ADAPTIV fiber can be found by visiting this page on the LYCRA® brand website.
About The LYCRA Company
The LYCRA Company innovates and produces fiber and technology solutions for the apparel and personal care industries. Headquartered in Wilmington, Delaware, The LYCRA Company is recognized worldwide for its innovative products, technical expertise, sustainable solutions, and unmatched marketing support. The LYCRA Company owns leading consumer and trade brands: LYCRA® , LYCRA HyFit® , LYCRA® T400® , COOLMAX® , THERMOLITE® , ELASPAN® , SUPPLEX® , and TACTEL® . The LYCRA Company’s legacy stretches back to 1958 with the invention of the original spandex yarn, LYCRA® fiber. Today, The LYCRA Company focuses on adding value to its customers’ products by developing unique innovations designed to meet the consumer’s need for comfort and lasting performance. For more information, visit www.thelycracompany.com .
LYCRA® is a trademark of The LYCRA Company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210914005789/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HUI (HUI:VSE) Merges Traditional and Crypto Finance: Commences Continuous Trading in Vienna With Leading Market Maker and Announces Impending Token Listing on Major Global Exchange15.6.2026 11:15:00 CEST | Press release
The first SaaS SuperApp for startups and VCs capitalizes on a $25M round a from Nimbus Capital and a +15% stock surge, unveiling a v3/v4 roadmap that bridges public equity with digital asset liquidity. HUI S.p.A., the pioneering vertical SuperApp and SaaS company dedicated to the global Venture Capital and startup ecosystem listed on the Vienna Stock Exchange, today released its global product strategy, marking an unprecedented convergence between traditional regulated markets and decentralized finance. Driven by a +15% stock surge and the consolidation of its $25 million round a equity commitment fully subscribed by global institutional fund Nimbus Capital, the company announced its upcoming transition to continuous trading on the Vienna market in partnership with a leading European market maker, alongside the activation of the initial PUT options tied to the round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026061293689
Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI15.6.2026 09:35:00 CEST | Press release
Agricultural innovation leader to contribute with agronomic expertise in building accurate crop health, pest forecasting and heat stress models India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the country to become one of the world’s leading producers of crops such as rice and wheat. However, farmers in the country face significant challenges – from erratic monsoons, severe droughts and unseasonal rains compounded by El Nino, to pests and diseases that destroy an estimated 30 percent of crops annually. More than 80 percent of India’s estimated 150 million farming households are composed of smallholder farmers who operate on less than two hectares of land. This limits economies of scale, sets obstacles to the wider adoption of advanced technologies and could widen a systemic gap between large commercial agricultural operations and the bulk of
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 09:00:00 CEST | Press release
The combination unites Pelago Bioscience’s industry-leading and proprietary cellular target engagement capabilities with RG Discovery’s deep medicinal chemistry and custom synthesis expertise - enabling customers to advance drug discovery programs across the full design-make-test-analyze-(DMTA) cycle with a single specialist partner. Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discover
LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 08:10:00 CEST | Press release
AI-native operations model enables enterprises to move from reactive service delivery to intelligent, outcome-driven managed services LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across sys
Azafaros to Present at BIO International Convention 202615.6.2026 07:00:00 CEST | Press release
Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom